Deciphera Pharmaceuticals, Inc. Annual Costs and Expenses in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Deciphera Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from 2018 to 2023.
  • Deciphera Pharmaceuticals, Inc. Costs and Expenses for the quarter ending March 31, 2024 was $93.8M, a 8.24% increase year-over-year.
  • Deciphera Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending March 31, 2024 was $381M, a 16.5% increase year-over-year.
  • Deciphera Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $374M, a 18.2% increase from 2022.
  • Deciphera Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $317M, a 20.1% decline from 2021.
  • Deciphera Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $396M, a 26.5% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $374M +$57.6M +18.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-07
2022 $317M -$79.5M -20.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-07
2021 $396M +$82.9M +26.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-07
2020 $313M +$87.6M +38.8% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-07
2019 $226M +$122M +117% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-08
2018 $104M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.